Skip to main content
Tech.euFundingExplorerBeta

A4Cell

A4Cell has developed SPAchip®, a technology that responds to one of the technological challenges we face today: to fully understand cell physiology.

Total raised
€4.3M
€4,250,000
Funding rounds
2
Investors
6
distinct backers
Active since
2021-12
latest 2023-11

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood24
base rate 30% for Other
  • Overdue vs cohort gap
  • Up-round momentum
  • Low backer re-investment
Exit likelihood12
base rate 12% (2+ rounds)

    Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

    Similar companies

    same sector or country